60 Degrees Pharmaceuticals, Inc. SXTP
0.49 USD -0.04 (-7.34%)
Nov 11, 2026, 2:51 PM EST
0.49 Day range 0.5205
0.48 52-week range 8.62
- YTD
- -75.81%
- 1 year
- -90.33%
Analyst view
Consensus: buy
Buy
Price target (mean) 3.40
Ratings (0m) 2 1 buy · 1 hold · 0 sell
- Strong buy0
- Buy1
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 2
- 1 month ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.65 | -0.65 – -0.65 | -1.88 | +65.5% | 234.00K | +86.2% | 1 |
| Next quarter | -0.67 | -0.67 – -0.67 | -1.58 | +57.5% | 300.00K | +157.6% | 1 |
| Current year | -5.68 | -5.68 – -5.68 | -23.07 | +75.4% | 622.50K | +145.5% | 1 |
| Next year | -2.71 | -2.71 – -2.71 | -5.68 | +52.3% | 1.65M | +165.2% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 23, 2024 | HC Wainwright & Co. | Reiterated | Neutral | Neutral |
| Dec 11, 2024 | HC Wainwright & Co. | Reiterated | Neutral | Neutral |
| Nov 15, 2024 | HC Wainwright & Co. | Reiterated | — | Neutral |
| Sep 13, 2024 | HC Wainwright & Co. | Reiterated | — | Neutral |
| Aug 15, 2024 | HC Wainwright & Co. | Reiterated | — | Neutral |
| Jun 6, 2024 | HC Wainwright & Co. | Reiterated | — | Neutral |
| Apr 3, 2024 | HC Wainwright & Co. | Reiterated | — | Neutral |
| Oct 20, 2023 | HC Wainwright & Co. | Initiated | — | Neutral |
| Oct 2, 2023 | Ascendiant Capital | Initiated | — | Buy |